FIELD: medicine.
SUBSTANCE: invention refers to medicine and may be used for treating anaemia or a red blood cell disorder in a patient having a condition, wherein the above condition is specified in a group consisting of sickle cell anaemia or rheumatoid disease. That is ensured by administering a therapeutically effective amount of lecithin cholesterol acyl transferase (LCAT) to the patient.
EFFECT: invention makes it possible to increase red blood cell weight and count in the patients suffering sickle cell anaemia and rheumatoid disease.
6 cl, 3 dwg, 2 tbl, 10 ex
